IN THE NEWS: Q&A: 'Promising' immunotherapies may treat platinum-resistant ovarian cancer

Healio

Ira Winer, M.D., Ph.D., FACOG, gynecologic oncologist, member of the Gynecologic Oncology and Phase1 Clinical Trials Multidisciplinary Teams at Karmanos, discusses the treatments currently under investigative study that show the most promise for platinum-resistant ovarian cancer.

Read the article here.